COVID19 Update: For your safety, you will be asked to use a mask, if you do not have one, a mask will be provided. If a person presents with a temperature, you will be asked to return home and further instructions will be given by your health care team. For our patients protection, no visitors under 18 will be allowed in the offices, there is a limit one (1) visitor per patient if necessary. No visitors are allowed in the chemo infusion room. Telemedicine are available for routine office visits. More Information-PLEASE CLICK HERE
Ivan Aksentijevich, MD
I take very seriously the privilege given to me when I am asked to help in a person’s care. An up-to-date, comprehensive and holistic approach to patient care allows us to achieve the best possible outcome.
Johns Hopkins University, Medical Oncology and Hematology
St. Agnes Hospital
University of Belgrade
University of Belgrade
Dr. Ivan Aksentijevich earned his Medical Doctor degree from the University of Belgrade, Serbia. After immigrating to the United States, he completed two post-doctoral research fellowships at the National Institutes of Health (NIH), in Bethesda, Maryland. During his first fellowship, Dr. Aksentijevich worked to isolate hematopoietic stem cells and induce donor specific host immune tolerance. Subsequently, he worked on developing methods to reverse cancer genes that confer cancer cells’ resistance. In recognition for his research achievements at NIH, Dr. Aksentijevich was awarded the National Institute of Health Biotechnology Award and the National Cancer Institute Technology Transfer Award.
Following his post-doctoral fellowships, Dr. Aksentijevich enrolled in a 3-year internal medicine residency program at St Agnes Hospital in Baltimore, Maryland, during which he earned two Regional American College of Physicians Clinical Awards. Dr. Aksentijevich went on to complete a fellowship in Hematology and Medical Oncology at Johns Hopkins University in Baltimore, Maryland. As part of his clinical fellowship training, he worked on developing clinical trials for patients with various hematologic malignancies. In recognition for his work on stem cell transplantation in patients with refractory non-Hodgkin’s lymphoma, Dr. Aksentijevich was awarded the American Society of Clinical Oncology Merit Award.
Dr. Aksentijevich has published over 30 scientific articles in leading peer-reviewed journals, including Blood, Journal of Clinical Oncology, Journal of Experimental Medicine, Transplantation Immunology, and Cancer. He has also authored several chapters on subjects ranging from leukemias to transplantation immunology and has been an invited guest speaker at leading national and international scientific meetings.
Dr. Aksentijevich has committed himself to providing the highest levels of patient care in his practice of clinical oncology. He treats patients afflicted with various malignancies, with a special focus on hematologic malignancies. He is board-certified by the American Board of Medical Oncology and the American Board of Hematology. He is a member of the American Society of Clinical Oncology and American Society of Hematology and has been consistently named as a Top Doctor in publications such as Northern Virginia magazine and Washingtonian magazine.
Outside of his practice, Dr. Aksentijevich enjoys travel, tennis, and spending time with his wife and his five daughters.
July 7, 2020
The Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of acute leukemia